Colleen A (Fotsch Lawton) Lawton MD FASTRO

Urologic Cancer

Professor, Radiation Oncology, Medical College of Wisconsin

9200 W Wisconsin AveDepartment Of Radiation OncologyMilwaukee, WI 53226
Phone+1 414-805-4400
Fax+1 414-805-4369

Dr. Lawton is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lawton's full profile Already have an account?

Education & Training

Medical College of Wisconsin Affiliated HospitalsResidency, Radiation Oncology, 1983 - 1987
Medical College of WisconsinClass of 1983

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

WI State Medical License 1984 - 2027
IL State Medical License 1985 - 1987
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Brachytherapy in Treating Patients With Prostate Cancer Start of enrollment: 1998 Sep 01
Completed
Phase 2
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy Start of enrollment: 2006 Mar 01
Completed
Phase 3
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
ACTIVE_NOT_RECRUITING
PHASE3

Publications & Presentations

PubMed

1 citations
Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials.
Krishnan R Patel, Paul L Nguyen, James A Proudfoot, Yang Liu, Alan Dal Pra
European Urology Oncology. 2026-04-01
Assessing Quality and Adherence to PI-RADSv2.1 Minimum Technical Standards of Prostate MRI in NRG-GU005.
Stephanie Alley, Marion Tonneau, Damien Olivié, Clare M Tempany-Afdhal, Peter L Choyke
Journal of Magnetic Resonance Imaging. 2026-02-01
3 citations
Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer: A Meta-Analysis.
Nicholas G Zaorsky, Yilun Sun, Abdenour Nabid, Almudena Zapatero, Michel Bolla
JAMA Oncology. 2026-01-01

Press Mentions

$MR Guidance and Hypofractionated RT for Prostate Cancer a Good Match$
MR Guidance and Hypofractionated RT for Prostate Cancer a Good MatchJune 22nd, 2022
POP-RT Trial Supports Whole-Pelvis Radiotherapy for High-Risk Prostate CancerJanuary 11th, 2021
Delaying RT for Higher-Risk Prostate Cancer Found SafeSeptember 2nd, 2020